Liquid Biopsy Market

Global Liquid Biopsy Market is valued at US$ 15.96 Billion in 2026 and it is expected to reach US$ 41.19 Billion by 2033 with a CAGR of 14.50% over the forecast period.

Liquid Biopsy Market: Increasing prevalence of cancer and rising demand for non-invasive procedures are key drivers for Global Liquid Biopsy Market.

Scope of Global Liquid Biopsy Market Reports –

Liquid Biopsy is a unique and non-invasive alternative tool to surgical biopsies and helps in determining an array of information about tumors through a simple test sample. According to the International Agency for Research on Cancer, by 2030 there will be over 22 million new cases a year, up from 14 million in 2012. There is a significant rise in prevalence of cancer globally. So, during the study of Global Liquid Biopsy market, we have considered Liquid Biopsy products and consumables to analyze the market.

Global Liquid Biopsy Market report is segmented on the basis of Product type, Biomarker type, Sample type, Application Type, End User type and by regional & country level. Based on Product type global Liquid Biopsy Market is classified as Instruments, Kits and Services. Based upon Biomarker, global Liquid Biopsy Market is classified as Cell-free DNAs (cfDNAs), Circulating tumor cells (CTCs) and Exosomes. Based upon Sample type, global Liquid Biopsy Market is classified as Blood, Urine, Serum/Plasma and others. Based upon Application type, global Liquid Biopsy Market is classified as Lung Cancer, Leukemia, Gastrointestinal Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer and others. Based upon End User type, global Liquid Biopsy Market is classified as Hospitals, Diagnostic Laboratories and Cancer Research Centers.

The regions covered in this Liquid Biopsy Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Liquid Biopsy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Liquid Biopsy Market Reports-

Global Liquid Biopsy market report covers prominent players like

• QIAGEN
• Adaptive Biotechnologies
• Johnson & Johnson
• ANGLE plc
• Biocept Inc.
• Bio-Rad Laboratories Inc.
• Cynvenio Biosystems Inc.
• Epic Sciences
• F. Hoffmann-La Roche Ltd.
• Genomic Health
• Guardant Health Inc.
• Illumina Inc.
• Janssen Diagnostics
• MDxHealth
• Menarini Silicon Biosystems
• Myriad Genetics
• Pathway Genomics Corporation
• NeoGenomics Laboratories Inc.
• RainDance Technologies Inc.
• Silicon Biosystems
• Thermo Fisher Scientific
• Trovagene Inc.
• Sysmex Corporation
• Exact Sciences Corporation
• Vortex Biosciences Inc.
• Exosome Diagnostics Inc.
• Agena Bioscience Inc.
• MedGenome Inc.

Global Liquid Biopsy Market Dynamics –

Increasing number of cancer patients, improvements in diagnostic testing, advancements in immunotherapy and targeted approaches and rising demand of non-invasive diagnostic procedures and personalized medicine

Market Segmentation

By Product Type

• Instruments
• Kits
• Services

By Biomarker Type

• Cell-free DNAs (cfDNAs)
• Circulating tumor cells (CTCs)
• Exosomes
• Others

By Sample Type

• Blood
• Urine
• Serum/Plasma
• Others

By Application

• Lung Cancer
• Leukemia
• Gastrointestinal Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Others

 By End User

• Hospitals
• Diagnostic Laboratories
• Cancer Research Centers

By Region

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA